These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 12744550

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Rash with both clopidogrel and ticlopidine in two patients following percutaneous coronary intervention with drug-eluting stents.
    Makkar K, Wilensky RL, Julien MB, Herrmann HC, Spinler SA.
    Ann Pharmacother; 2006 Jun; 40(6):1204-7. PubMed ID: 16684808
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Clopidogrel for prevention of major cardiac events after coronary stent implantation: 30-day and 6-month results in patients with smaller stents.
    Calver AL, Blows LJ, Harmer S, Dawkins KD, Gray HH, Morgan JH, Simpson IA.
    Am Heart J; 2000 Sep; 140(3):483-91. PubMed ID: 10966552
    [Abstract] [Full Text] [Related]

  • 5. Clopidogrel desensitization: case report and review of published protocols.
    Owen P, Garner J, Hergott L, Page RL.
    Pharmacotherapy; 2008 Feb; 28(2):259-70. PubMed ID: 18225971
    [Abstract] [Full Text] [Related]

  • 6. [Hepatic toxicity and clopidogrel-induced systemic inflammatory response syndrome].
    López-Vicente J, Garfia C, López-Medrano F, Yela C.
    Rev Esp Cardiol; 2007 Mar; 60(3):323-4. PubMed ID: 17394881
    [No Abstract] [Full Text] [Related]

  • 7. Prolonged clopidogrel use after bare metal and drug-eluting stent placement: the Veterans Administration drug-eluting stent study.
    Faxon DP, Lawler E, Young M, Gaziano M, Kinlay S.
    Circ Cardiovasc Interv; 2012 Jun; 5(3):372-80. PubMed ID: 22668555
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Recovery of platelet function after discontinuation of prasugrel or clopidogrel maintenance dosing in aspirin-treated patients with stable coronary disease: the recovery trial.
    Price MJ, Walder JS, Baker BA, Heiselman DE, Jakubowski JA, Logan DK, Winters KJ, Li W, Angiolillo DJ.
    J Am Coll Cardiol; 2012 Jun 19; 59(25):2338-43. PubMed ID: 22698488
    [Abstract] [Full Text] [Related]

  • 12. Dose comparisons of clopidogrel and aspirin in acute coronary syndromes.
    CURRENT-OASIS 7 Investigators, Mehta SR, Bassand JP, Chrolavicius S, Diaz R, Eikelboom JW, Fox KA, Granger CB, Jolly S, Joyner CD, Rupprecht HJ, Widimsky P, Afzal R, Pogue J, Yusuf S.
    N Engl J Med; 2010 Sep 02; 363(10):930-42. PubMed ID: 20818903
    [Abstract] [Full Text] [Related]

  • 13. Clopidogrel desensitization after drug-eluting stent placement.
    von Tiehl KF, Price MJ, Valencia R, Ludington KJ, Teirstein PS, Simon RA.
    J Am Coll Cardiol; 2007 Nov 20; 50(21):2039-43. PubMed ID: 18021870
    [Abstract] [Full Text] [Related]

  • 14. Usefulness of platelet response to clopidogrel by point-of-care testing to predict bleeding outcomes in patients undergoing percutaneous coronary intervention (from the Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty-Bleeding Study).
    Patti G, Pasceri V, Vizzi V, Ricottini E, Di Sciascio G.
    Am J Cardiol; 2011 Apr 01; 107(7):995-1000. PubMed ID: 21256470
    [Abstract] [Full Text] [Related]

  • 15. Anti-platelet pre-treatment for atrial fibrillation patients on warfarin referred for coronary angiography/stenting because of non-ST-elevation acute coronary syndrome: An alternative proposal.
    Rubboli A, Di Pasquale G.
    Int J Cardiol; 2015 Dec 15; 201():494-6. PubMed ID: 26318509
    [No Abstract] [Full Text] [Related]

  • 16. Adding cilostazol to dual antiplatelet therapy achieves greater platelet inhibition than high maintenance dose clopidogrel in patients with acute myocardial infarction: Results of the adjunctive cilostazol versus high maintenance dose clopidogrel in patients with AMI (ACCEL-AMI) study.
    Jeong YH, Hwang JY, Kim IS, Park Y, Hwang SJ, Lee SW, Kwak CH, Park SW.
    Circ Cardiovasc Interv; 2010 Feb 01; 3(1):17-26. PubMed ID: 20118150
    [Abstract] [Full Text] [Related]

  • 17. Effect of atorvastatin and pravastatin on platelet inhibition by aspirin and clopidogrel treatment in patients with coronary stent thrombosis.
    Wenaweser P, Windecker S, Billinger M, Cook S, Togni M, Meier B, Haeberli A, Hess OM.
    Am J Cardiol; 2007 Feb 01; 99(3):353-6. PubMed ID: 17261397
    [Abstract] [Full Text] [Related]

  • 18. The safety of clopidogrel.
    Mangalpally KK, Kleiman NS.
    Expert Opin Drug Saf; 2011 Jan 01; 10(1):85-95. PubMed ID: 21091040
    [Abstract] [Full Text] [Related]

  • 19. Comparison of platelet reactivity and clopidogrel response in patients ≤ 75 Years Versus > 75 years undergoing percutaneous coronary intervention for non-ST-segment elevation acute coronary syndrome.
    Cuisset T, Quilici J, Grosdidier C, Fourcade L, Gaborit B, Pankert M, Molines L, Morange PE, Bonnet JL, Alessi MC.
    Am J Cardiol; 2011 Nov 15; 108(10):1411-6. PubMed ID: 21872198
    [Abstract] [Full Text] [Related]

  • 20. Clinical management of clopidogrel inefficiency by point of care platelet function testing and individual adjustment of anti-platelet therapy--initial experiences.
    Schuhmann CG, Sohn HY, Nagel J, Spannagl M, Klauss V, Krötz F.
    Platelets; 2009 Nov 15; 20(7):498-504. PubMed ID: 19852689
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.